Update on AIN

It is a great honor to have been awarded the third position of the JLGTD 2023 Edward J. Wilkinson Best Paper Award with the paper "A**l Intraepithelial Neoplasia and A**l Squamous Cell Carcinoma: Updates From the Last 3 Years."

I will also be presenting this paper on an online session at the 2024 American Society for Colposcopy and Cervical Pathology (ASCCP) anual Meeting.

Vulvar neoplasia as a risk factor for a**l cancer.

Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for A**l Cancer: A Review - PubMed Clinicians need be aware that women with vHSIL and VSCC comprise one of the highest-risk groups for ASCC. Inquiring suggestive symptoms of ASCC and a digital anorectal examination can help in the early detection of this type of cancer.

IPVC 2021 Special Interest Satellite Symposium 12: A**l cancer and precancerous lesions: what´s new?

Conference Calendar - The 34th International Papillomavirus Conference The title of the BD Symposium will be, “Screening Smarter in the Post-Pandemic Era: The Clinical Utility of Extended Genotyping and Self-Collection”. The moderator, Marie-Hélène Mayrand, MD, PhD, FRCSC of the Université de Montréal will introduce the symposium and the three symposium speaker...

HPV vaccination might not provide benefit on HIV-infected adults aged ≥27 years to prevent new a**l HPV infections or to improve a**l precancerous lesions outcomes.

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298 - PubMed NCT01461096.